BDO provided financial and tax due diligence services to Avania on its acquisition of Boston Biomedical Associates.
Kester Capital portfolio company, Avania, is a leading global contract research organization (CRO) focused on medical devices and in vitro diagnostics (IVDs).
BBA is a premier full-service medical device/biotechnology CRO and consultancy based in the US.
The merger further advances the shared strategic vision to become the leading global medical device and medical technology focused CRO. Following the recent acquisitions of Five Corners, MileStone Research Organization and Clinical Device Group, the Factory-CRO Group now has specialized operations and expertise in the US, Europe and Australia/New Zealand. This global expansion coupled with the diverse medical therapeutic expertise provides a means to efficiently service clients.